AAAAAA

   
Results: 1-16 |
Results: 16
EPIRUBICIN AS A SINGLE-AGENT IN COMPARISON TO CMF IN ADJUVANT THERAPYOF STAGE-I AND STAGE-II BREAST-CANCER
Authors: COLOZZA M BISAGNI G MOSCONI AM GORI C BONI C BIAN AR SABBATINI R FRASSOLDATI A PASSALACQUA R RODINO C RONDINI E ALGERI R DISARRA S BACCHI M TONATO M COCCONI G
Citation: M. Colozza et al., EPIRUBICIN AS A SINGLE-AGENT IN COMPARISON TO CMF IN ADJUVANT THERAPYOF STAGE-I AND STAGE-II BREAST-CANCER, European journal of cancer, 34, 1998, pp. 86-86
MITOXANTRONE (M) AND TAXOL (T) AS FIRST LINE CHEMOTHERAPY IN PATIENTSWITH ADVANCED BREAST-CANCER (ABC)
Authors: DICOSTANZO F SDROBOLINI A MANZIONE L BILANCIA D DINOTA A ROCCA A GASPERONI S GIUSTINI L ACITO L COLOZZA MA GORI S MOSCONI AM CONTU A
Citation: F. Dicostanzo et al., MITOXANTRONE (M) AND TAXOL (T) AS FIRST LINE CHEMOTHERAPY IN PATIENTSWITH ADVANCED BREAST-CANCER (ABC), Annals of oncology, 9, 1998, pp. 111-111
GEMCITABINE AS 2ND-LINE TREATMENT FOR RELAPSING OR REFRACTORY ADVANCED NONSMALL CELL LUNG-CANCER - A PHASE-II TRIAL
Authors: CRINO L MOSCONI AM SCAGLIOTTI GV SELVAGGI G RINALDI M DELLAGIULIA M GRIDELLI C CALANDRI C DEMARINIS F NOSEDA M TONATO M
Citation: L. Crino et al., GEMCITABINE AS 2ND-LINE TREATMENT FOR RELAPSING OR REFRACTORY ADVANCED NONSMALL CELL LUNG-CANCER - A PHASE-II TRIAL, Seminars in oncology, 25(4), 1998, pp. 23-26
GEMCITABINE IN ADVANCED PANCREATIC-CANCER - A PHASE-II TRIAL
Authors: CRINO L MOSCONI AM CALANDRI C CORGNA E DARWISH S TONATO M
Citation: L. Crino et al., GEMCITABINE IN ADVANCED PANCREATIC-CANCER - A PHASE-II TRIAL, European journal of cancer, 33, 1997, pp. 1266-1266
COMBINATION THERAPY WITH GEMCITABINE IN NONSMALL CELL LUNG-CANCER
Authors: MOSCONI AM CRINO L TONATO M
Citation: Am. Mosconi et al., COMBINATION THERAPY WITH GEMCITABINE IN NONSMALL CELL LUNG-CANCER, European journal of cancer, 33, 1997, pp. 14-17
A BETTER THERAPEUTIC PROFILE FOR THE COMBINATION OF MITOMYCIN-C, IFOSFAMIDE AND CISPLATIN (MIC) IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A USEFUL DOSE-SCHEDULE MODIFICATION
Authors: CRINO L CORGNA E PORROZZI S PALLADINO MA DARWISH S MINOTTI V MOSCONI AM TONATO M
Citation: L. Crino et al., A BETTER THERAPEUTIC PROFILE FOR THE COMBINATION OF MITOMYCIN-C, IFOSFAMIDE AND CISPLATIN (MIC) IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A USEFUL DOSE-SCHEDULE MODIFICATION, Annals of oncology, 8(7), 1997, pp. 709-711
DELAYED EMESIS INDUCED BY MODERATELY EMETOGENIC CHEMOTHERAPY - DO WE NEED TO TREAT ALL PATIENTS
Authors: BALLATORI E ROILA F DEANGELIS V RIVA E BARBIERI P DELFAVERO A BASURTO C CICCARESE G PALLADINO MA MOSCONI AM ANASTASI P PICCIAFUOCO M CAMPORA E CHIARA S COGNETTI F FERRARESI V FABI A TONACHELLA R CIRULLI S SABBATINI R FEDERICO M TRASSOLDATI A SILINGARDI V DONATI D MAESTRI A MALACARNE P RICCI S ANTONUZZO A ALLEGRINI G CONTE PF SALVATI F NUNZIATI F ANTILLI A CATALANO G CASCINU S DICOSTANZO F TAGLIAVENTI M ZANIBONI A MERIGGI F CORTESI E RAMPONI S LOCATELLI MC SANTORO A ZUCCHINELLI P MANTELLINI E FERRETTI G BONI C MORETTI G SCAGLIOTTI G DANIELE O LISSONI A TATEO S
Citation: E. Ballatori et al., DELAYED EMESIS INDUCED BY MODERATELY EMETOGENIC CHEMOTHERAPY - DO WE NEED TO TREAT ALL PATIENTS, Annals of oncology, 8(6), 1997, pp. 561-567
CISPLATIN-GEMCITABINE COMBINATION IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A PHASE-II STUDY
Authors: CRINO L SCAGLIOTTI G MARANGOLO M FIGOLI F CLERICI M DEMARINIS F SALVATI F CRUCIANI G DOGLIOTTI L PUCCI F PACCAGNELLA A ADAMO V ALTAVILLA G INCORONATO P TRIPPETTI M MOSCONI AM SANTUCCI A SORBOLINI S OLIVA C TONATO M
Citation: L. Crino et al., CISPLATIN-GEMCITABINE COMBINATION IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A PHASE-II STUDY, Journal of clinical oncology, 15(1), 1997, pp. 297-303
LONG-TERM RESULTS IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CARCINOMA TREATED WITH A COMBINATION OF CISPLATIN, DOXORUBICIN, AND CYCLOPHOSPHAMIDE
Authors: COLOZZA M MOSCONI AM GORI S BELSANTI V BASURTO C DEANGELIS V GIANSANTI M TONATO M
Citation: M. Colozza et al., LONG-TERM RESULTS IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CARCINOMA TREATED WITH A COMBINATION OF CISPLATIN, DOXORUBICIN, AND CYCLOPHOSPHAMIDE, American journal of clinical oncology, 20(5), 1997, pp. 522-526
RATIONALE OF A PHASE-III STUDY COMPARING A STANDARD CISPLATIN REGIMEN(MITOMYCIN IFOSFAMIDE/CISPLATIN) WITH CISPLATIN AND GEMCITABINE IN NONSMALL CELL LUNG-CANCER/
Authors: TONATO M CRINO L MOSCONI AM
Citation: M. Tonato et al., RATIONALE OF A PHASE-III STUDY COMPARING A STANDARD CISPLATIN REGIMEN(MITOMYCIN IFOSFAMIDE/CISPLATIN) WITH CISPLATIN AND GEMCITABINE IN NONSMALL CELL LUNG-CANCER/, Seminars in oncology, 24(3), 1997, pp. 831-835
INDUCTION CHEMOTHERAPY WITH CISPLATIN, DOXORUBICIN, AND CYCLOPHOSPHAMIDE (CAP) IN A COMBINED-MODALITY APPROACH FOR LOCALLY ADVANCED AND INFLAMMATORY BREAST-CANCER - LONG-TERM RESULTS
Authors: COLOZZA M GORI S MOSCONI AM ANASTASI P DEANGELIS V GIANSANTI M MERCATI U ARISTEI C LATINI P TONATO M
Citation: M. Colozza et al., INDUCTION CHEMOTHERAPY WITH CISPLATIN, DOXORUBICIN, AND CYCLOPHOSPHAMIDE (CAP) IN A COMBINED-MODALITY APPROACH FOR LOCALLY ADVANCED AND INFLAMMATORY BREAST-CANCER - LONG-TERM RESULTS, American journal of clinical oncology, 19(1), 1996, pp. 10-17
SALVAGE CHEMOTHERAPY IN METASTATIC BREAST-CANCER - AN EXPERIENCE WITHTHE COMBINATION OF MITOXANTRONE, 5-FLUOROURACIL, AND L-LEUCOVORIN
Authors: COLOZZA M GORI S MOSCONI AM ANASTASI P BASURTO C LUDOVINI V DEANGELIS V GIANSANTI M TONATO M
Citation: M. Colozza et al., SALVAGE CHEMOTHERAPY IN METASTATIC BREAST-CANCER - AN EXPERIENCE WITHTHE COMBINATION OF MITOXANTRONE, 5-FLUOROURACIL, AND L-LEUCOVORIN, Breast cancer research and treatment, 38(3), 1996, pp. 277-282
GEMCITABINE-CISPLATIN COMBINATION IN NON-SMALL-CELL LUNG-CANCER (NSCLC) - A PHASE-II STUDY
Authors: CRINO L SEAGLIOTTI G MARANGOLO M FIGOLI F CLERICI M DEMARINIS F SALVATI F CRUCIANI G DOGLIOTTI L COCCONI G PACCAGNELLA A ADAMO V INCORONATO P SCARCELLA L MOSCONI AM TONATO M
Citation: L. Crino et al., GEMCITABINE-CISPLATIN COMBINATION IN NON-SMALL-CELL LUNG-CANCER (NSCLC) - A PHASE-II STUDY, European journal of cancer, 31A, 1995, pp. 1064-1064
SAFETY PROFILE OF GEMCITABINE
Authors: TONATO M MOSCONI AM MARTIN C
Citation: M. Tonato et al., SAFETY PROFILE OF GEMCITABINE, Anti-cancer drugs, 6, 1995, pp. 27-32
PERSISTENCE OF EFFICACY OF 3 ANTIEMETIC REGIMENS AND PROGNOSTIC FACTORS IN PATIENTS UNDERGOING MODERATELY EMETOGENIC CHEMOTHERAPY
Authors: BALLATORI E ROILA F DEANGELIS V TONATO M RIVA E BARBIERI P DELFAVERO A BASURTO C CICCARESE G PALLADINO MA MOSCONI AM ANASTASI P PICCIAFUOCO M CAMPORA E CHIARA S COGNETTI F FERRARESI V FABI A COLELLA E CIRULLI S SABBATINI R FEDERICO M BARBIERI F SILINGARDI V ANNA S DONATI D MAESTRI A MALACARNE P RICCI S ANTONUZZO A CONTE PF SALVATI F NUNZIATI F ANTILLI A CATALANO G CASCINU S DICOSTANZO F TAGLIAVENTI M ZANIBONI Z MERIGGI F CORTESI E CALABRO F CARLO S LUPORINI G DANTONA A SANTORO A GIACOBONE A MANTELLINI E FERRETTI G BONI C MORETTI G SCAGLIOTTI G DANIELE O LISSONI A TATEO S
Citation: E. Ballatori et al., PERSISTENCE OF EFFICACY OF 3 ANTIEMETIC REGIMENS AND PROGNOSTIC FACTORS IN PATIENTS UNDERGOING MODERATELY EMETOGENIC CHEMOTHERAPY, Journal of clinical oncology, 13(9), 1995, pp. 2417-2426
DEXAMETHASONE, GRANISETRON, OR BOTH FOR THE PREVENTION OF NAUSEA AND VOMITING DURING CHEMOTHERAPY FOR CANCER
Authors: ROILA F BALLATORI E DEANGELIS V TONATO M RIVA E PANZA MT DELFAVERO A BASURTO C CICCARESE G PALLADINO MA MOSCONI AM ANASTASI P PICCIAFUOCO M CAMPORA E CHIARA S ROSSO R COGNETTI F FERRARESI V FABI A TONACHELLA R CIRULLI S SABBATINI R FEDERICO M DEPENNI R SILINGARDI V DONATI D MAESTRI A MALACARNE P RICCI S MUTTINI MP CONTE PF SALVATI F NUNZIATI F SIGNORA M CATALANO G CASCINU S DICOSTANZO F TAGLIAVENTI M ZANIBONI A MERIGGI F CORTESI E TRINCA C LUPORINI G LOCATELLI MC SANTORO A ZUCCHINELLI P MANTELLINI E FERRETTI G BONI C MORETTI G SCAGLIOTTI G DANIELE O LISSONI A TATEO S
Citation: F. Roila et al., DEXAMETHASONE, GRANISETRON, OR BOTH FOR THE PREVENTION OF NAUSEA AND VOMITING DURING CHEMOTHERAPY FOR CANCER, The New England journal of medicine, 332(1), 1995, pp. 1-5
Risultati: 1-16 |